Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HS2Z
|
||||
Former ID |
DIB013222
|
||||
Drug Name |
GPR119 agonists
|
||||
Synonyms |
GPR119 agonists (diabetes); GPR119 agonists (diabetes), Schering-Plough
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [552050] | ||
Company |
Schering-Plough Research Institute
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(C1CC1)N1[C@H]2CC[C@@H]1C[C@@H](Oc1c(c(Nc3c(cc(c<br />c3)C#N)Cl)ncn1)C)C2
|
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [543393] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.